Meiling Shen
Impact in
- Immunology top 2%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Hepatology top 2%
- Hepatitis C virus research
Papers in
- Immunology 12
- Immune cells in cancer 6
- Immunotherapy and Immune Responses 5
-
- Nanoplatforms for cancer theranostics 15
- Co-authors
- Faruk G. Sheikh (1 shared paper)Jerome A. Langer (1 shared paper)Raymond P. Donnelly (1 shared paper)Grant E. Gallagher (1 shared paper)Harold L. Dickensheets (1 shared paper)Sergei V. Kotenko (1 shared paper)Anita Lewis-Antes (1 shared paper)Changyang Gong (22 shared papers)
- Journals
- Biomaterials (4 papers)Advanced Science (3 papers)Theranostics (2 papers)Chemical Engineering Journal (2 papers)ACS Nano (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Meiling Shen
34 papers receiving 2.2k citations
Meiling Shen's Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology 1.1k
- Hepatology 342
- Oncology 497
- Epidemiology 424
- Infectious Diseases 230
Countries citing papers authored by Meiling Shen
This map shows the geographic impact of Meiling Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Shen more than expected).
Fields of papers citing papers by Meiling Shen
This network shows the impact of papers produced by Meiling Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Shen. The network helps show where Meiling Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex Hit paper breakdown → | 2002 | 1600 |
| 2 | 2020 | 65 | |
| 3 | 1989 | 57 | |
| 4 | 2021 | 50 | |
| 5 | 2022 | 49 | |
| 6 | 2022 | 44 | |
| 7 | 2020 | 38 | |
| 8 | 2023 | 26 | |
| 9 | 2020 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2022 | 21 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 20 | |
| 14 | 2022 | 17 | |
| 15 | 2021 | 17 | |
| 16 | 2018 | 17 | |
| 17 | 2024 | 16 | |
| 18 | 2023 | 16 | |
| 19 | 1994 | 14 | |
| 20 | 2023 | 12 |
About Meiling Shen
Meiling Shen is a scholar working on Immunology, Biomedical Engineering, Toxicology, Oncology and Pharmacology, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Immune cells in cancer (6 papers), Advanced Nanomaterials in Catalysis (5 papers), Immunotherapy and Immune Responses (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Forensic Toxicology and Drug Analysis (3 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Immunology (1.1k citations), Hepatology (342 citations), Oncology (497 citations), Epidemiology (424 citations) and Infectious Diseases (230 citations). Meiling Shen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Faruk G. Sheikh, Jerome A. Langer, Raymond P. Donnelly, Grant E. Gallagher, Harold L. Dickensheets, Sergei V. Kotenko, Anita Lewis-Antes, Changyang Gong, Qinjie Wu and Lu Li. Their work appears in journals such as Biomaterials, Advanced Science, Theranostics, Chemical Engineering Journal and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.